Search research articles
Contact Us
Filters
Showing results (171-180 of 183) with videos related to
Page
of 19
Sort By:
Journal of Visualized Experiments : Jove
|
January 22, 2024
Multiplexed Live-Cell Imaging for Drug Responses in Patient-Derived Organoid Models of Cancer
Kaitriana E Colling, Emily L Symons, Lorenzo Buroni, et al.
The Journal of the Canadian Chiropractic Association
|
January 22, 2019
SafetyNET Community-based patient safety initiatives: development and application of a Patient Safety and Quality Improvement Survey
Martha Funabashi, Katherine A Pohlman, Silvano Mior, et al.
Biorxiv : the Preprint Server for Biology
|
November 28, 2023
Multiplexed live-cell imaging for drug responses in patient-derived organoid models of cancer
Kaitriana E Colling, Emily L Symons, Lorenzo Buroni, et al.
Scientific Reports
|
November 18, 2022
Characterization of HCI-EC-23 a novel estrogen- and progesterone-responsive endometrial cancer cell line
Craig M Rush, Zannel Blanchard, Jacob T Polaski, et al.
Cancer Management and Research
|
June 27, 2019
An integrated prediction model of recurrence in endometrial endometrioid cancers
Marina D Miller, Erin A Salinas, Andreea M Newtson, et al.
Oncotarget
|
September 18, 2014
Systematic dissection of the mechanisms underlying progesterone receptor downregulation in endometrial cancer
Shujie Yang, Yichen Jia, Xiaoyue Liu, et al.
International Journal of Molecular Sciences
|
March 13, 2019
A Prediction Model for Preoperative Risk Assessment in Endometrial Cancer Utilizing Clinical and Molecular Variables
Erin A Salinas, Marina D Miller, Andreea M Newtson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 6, 2022
<i>TP53</i> Sequencing and p53 Immunohistochemistry Predict Outcomes When Bevacizumab Is Added to Frontline Chemotherapy in Endometrial Cancer: An NRG Oncology/Gynecologic Oncology Group Study
Kristina W Thiel, Eric J Devor, Virginia L Filiaci, et al.
Radiation Oncology (London, England)
|
October 28, 2024
Influence of brain metastases on the classification, treatment, and outcome of patients with extracranial oligometastasis: a single-center cross-sectional analysis
Sebastian M Christ, Gabriel W Thiel, Philip Heesen, et al.
Gynecologic Oncology
|
May 24, 2017
High stathmin expression is a marker for poor clinical outcome in endometrial cancer: An NRG oncology group/gynecologic oncology group study
Henry D Reyes, Jeffrey Miecznikowski, Jesus Gonzalez-Bosquet, et al.
Page
of 19
Search research articles
Search
Showing results (171-180 of 183) with videos related to
Sort By:
Page
of 19
Journal of Visualized Experiments : Jove
|
January 22, 2024
Multiplexed Live-Cell Imaging for Drug Responses in Patient-Derived Organoid Models of Cancer
Kaitriana E Colling, Emily L Symons, Lorenzo Buroni, et al.
The Journal of the Canadian Chiropractic Association
|
January 22, 2019
SafetyNET Community-based patient safety initiatives: development and application of a Patient Safety and Quality Improvement Survey
Martha Funabashi, Katherine A Pohlman, Silvano Mior, et al.
Biorxiv : the Preprint Server for Biology
|
November 28, 2023
Multiplexed live-cell imaging for drug responses in patient-derived organoid models of cancer
Kaitriana E Colling, Emily L Symons, Lorenzo Buroni, et al.
Scientific Reports
|
November 18, 2022
Characterization of HCI-EC-23 a novel estrogen- and progesterone-responsive endometrial cancer cell line
Craig M Rush, Zannel Blanchard, Jacob T Polaski, et al.
Cancer Management and Research
|
June 27, 2019
An integrated prediction model of recurrence in endometrial endometrioid cancers
Marina D Miller, Erin A Salinas, Andreea M Newtson, et al.
Oncotarget
|
September 18, 2014
Systematic dissection of the mechanisms underlying progesterone receptor downregulation in endometrial cancer
Shujie Yang, Yichen Jia, Xiaoyue Liu, et al.
International Journal of Molecular Sciences
|
March 13, 2019
A Prediction Model for Preoperative Risk Assessment in Endometrial Cancer Utilizing Clinical and Molecular Variables
Erin A Salinas, Marina D Miller, Andreea M Newtson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 6, 2022
<i>TP53</i> Sequencing and p53 Immunohistochemistry Predict Outcomes When Bevacizumab Is Added to Frontline Chemotherapy in Endometrial Cancer: An NRG Oncology/Gynecologic Oncology Group Study
Kristina W Thiel, Eric J Devor, Virginia L Filiaci, et al.
Radiation Oncology (London, England)
|
October 28, 2024
Influence of brain metastases on the classification, treatment, and outcome of patients with extracranial oligometastasis: a single-center cross-sectional analysis
Sebastian M Christ, Gabriel W Thiel, Philip Heesen, et al.
Gynecologic Oncology
|
May 24, 2017
High stathmin expression is a marker for poor clinical outcome in endometrial cancer: An NRG oncology group/gynecologic oncology group study
Henry D Reyes, Jeffrey Miecznikowski, Jesus Gonzalez-Bosquet, et al.
Page
of 19